No results for ‘’
Krsnaa Diagnostics Ltd
₹546.65
(1.23%)
Tue, 28 Jul 2026, 01:20 am
Health Services
Medical/Nursing Services
24.5KKrsnaa Diagnostics Price to Cash Flow Ratio
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 21.22 | 23.85 | 35.52 | 33.34 |
| Price to book ratio | 0 | 0 | 0 | 0 | 2.23 | 1.96 | 2.45 | 2.87 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 3.19 | 3.04 | 3.26 | 3.61 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 11.23 | 18.27 | 90.46 | 30.75 |
| Enterprise value | 0 | 0 | 0 | 0 | 1250Cr | 1405Cr | 2004Cr | 2723Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 9.45 | 11.33 | 13.75 | 14.20 |
| Debt to equity ratio | 0 | 0 | 0 | 1 | 0.06 | 0.04 | 0.20 | 0.23 |
| Return on equity % | 0 | 0 | 0 | 1060 | 14.93 | 8.73 | 7.34 | 9.17 |
Krsnaa Diagnostics Ltd Price to Cash Flow Ratio
The Krsnaa Diagnostics Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Krsnaa Diagnostics Ltd's valuation, profitability, and overall financial performance. Tracking the Krsnaa Diagnostics Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Krsnaa Diagnostics Ltd (NSE: KRSNAA, BSE: 543328) is currently trading at ₹546.65, with a market capitalization of ₹1758.18Cr. As a leading company in the Health services sector and Medical/Nursing services industry, monitoring the Krsnaa Diagnostics Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Krsnaa Diagnostics Ltd Price to Cash Flow Ratio Current Value
The current Krsnaa Diagnostics Ltd Price to Cash Flow Ratio stands at 30.75.
The Krsnaa Diagnostics Ltd Price to Cash Flow Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Krsnaa Diagnostics Ltd Price to Cash Flow Ratio Historical Trend
The Krsnaa Diagnostics Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 30.75
- 2023: 90.46
- 2022: 18.27
- 2021: 11.23
- 2020: 0
The decline in Krsnaa Diagnostics Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Krsnaa Diagnostics Ltd Price to Cash Flow Ratio Indicates for Investors
The Krsnaa Diagnostics Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Krsnaa Diagnostics Ltd Price to Cash Flow Ratio Analysis Summary
The Krsnaa Diagnostics Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Krsnaa Diagnostics Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Krsnaa Diagnostics Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.